Avantor, an LBO'd lab supplier, files for an estimated $1.5 billion IPO

Shutterstock photo

Avantor, a LBO'd provider of laboratory supplies and services, filed on Friday with the SEC to raise up to an estimated $1.5 billion in an initial public offering.

The Radnor, PA-based company was founded in 1904 and booked $5.1 billion in sales for the 12 months ended September 30, 2018. Goldman Sachs and J.P. Morgan are the joint bookrunners on the deal. The company did not disclose a proposed ticker or exchange.

The article Avantor, an LBO'd lab supplier, files for an estimated $1.5 billion IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital


Research Brokers before you trade

Want to trade FX?